Login
Novartis (ADR) NYSE: NVS
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide
| Name | Novartis (ADR) |
| Ticker | NVS |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
|
Price
52W Low/High |
91.57
78.07 / 98.47 |
| Momentum | Neutral |
| Market cap | 206 B |
| 1Y Total Return |
12.74 %
Subpar |
| 1Y Volatility |
17.58 %
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide
Details
| Ticker | NVS |
| Name | Novartis (ADR) |
| ISIN | US66987V1098 |
| CUSIP | 66987V109 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | Switzerland |
| Currency | U.S. Dollar |
Share as of 07/23/2021
| Close Price | 91.57 |
| 52W Low/High | 78.07 / 98.47 |
| Market cap | 206 B |
| 1Y Total Return |
12.74 %
Subpar |
| 1Y Volatility |
17.58 %
Low Risk |
| Beta | 0.34 |
| PE (trailing) |
23.18
Mid-tier |
| 12M Dividends | 3.378 |
| Last Dividend Date | 03/04/2021 |
| Dividend Yield | 3.69 % |
Fin. Strength
| Net Profit Margin | 17.4 % |
| Cash from Op. / Cur. Liabilities | 0.45 |
| Diluted Earnings / Share | 3.95 |
| ROE | 16.7 % |
| ROIC | 10.4 % |
| Price / Revenue | 4.0 |
| Price / Book | 3.8 |
| Price / CF | 15.4 |
| Current Ratio | 0.8 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 0.66 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Revenue |
51,556
|
49,528
|
46,762
|
41,941
|
49,226
|
49,778
|
|
| Gross Profit |
35,633
|
34,609
|
32,604
|
29,662
|
32,006
|
32,178
|
|
| R&D |
9,230
|
9,553
|
8,731
|
8,266
|
9,039
|
8,893
|
|
| EBITDA |
20,682
|
20,176
|
21,776
|
16,095
|
17,502
|
17,630
|
|
| Operating Income |
10,950
|
9,277
|
8,506
|
9,302
|
7,926
|
8,455
|
|
| Net Income exc. Extra |
8,984
|
7,210
|
11,383
|
13,850
|
6,543
|
6,757
|
|
| per Share | |||||||
| Diluted avg Shares |
2,258
|
2,306
|
2,333
|
2,347
|
2,373
|
2,401
|
|
| EPS exc. Extra |
3.95
|
3.16
|
4.87
|
5.89
|
2.74
|
2.82
|
|
| Dividend |
3.38
|
3.04
|
13.45
|
2.21
|
2.33
|
2.76
|
|
| Div. Yield (an.) |
3.70 %
|
3.48 %
|
14.73 %
|
2.92 %
|
2.79 %
|
3.35 %
|
|
| Balance Sheet | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Total Assets |
124,015
|
123,763
|
116,294
|
142,058
|
133,749
|
131,436
|
|
| Cash, Eq & Invt ShortTerm |
5,356
|
6,293
|
10,335
|
13,146
|
8,437
|
5,740
|
|
| Total Current Assets |
23,808
|
23,882
|
28,320
|
32,065
|
26,538
|
23,722
|
|
| Total Non-Current Assets |
100,207
|
99,881
|
87,974
|
109,993
|
107,211
|
107,714
|
|
| Intangibles |
64,584
|
65,769
|
53,754
|
74,610
|
63,079
|
64,743
|
|
| Total Liabilities |
69,887
|
69,878
|
64,790
|
65,157
|
63,771
|
58,904
|
|
| Total Current Liabilities |
29,633
|
29,382
|
30,111
|
27,943
|
26,146
|
26,271
|
|
| Long Term Debt |
40,254
|
40,496
|
34,679
|
37,214
|
37,625
|
32,633
|
|
| Shareholder equity |
54,042
|
53,812
|
51,426
|
76,815
|
69,919
|
72,456
|
|
| Cash Flow | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Cash from Operations |
13,423
|
14,591
|
13,339
|
13,450
|
12,449
|
11,936
|
|
| Depreciation |
8,945
|
10,223
|
8,206
|
-386
|
9,156
|
9,114
|
|
| Cash from Investing |
-1,739
|
-13,646
|
-4,967
|
-1,451
|
-3,263
|
-4,059
|
|
| Capex |
1,198
|
1,244
|
437
|
1,038
|
2,147
|
1,744
|
|
| Cash from Financing |
-12,515
|
-5,088
|
-10,879
|
-7,409
|
-6,045
|
-7,640
|
|
| Stock Issued |
-5,362
|
-2,246
|
-3,385
|
-2,646
|
-3,548
|
-4,228
|
|
| Debt (LT) Issued |
169
|
4,371
|
-4,157
|
2,379
|
3,989
|
3,022
|
|
| Free Cash Flow |
17,200
|
19,315
|
23,267
|
12,401
|
11,373
|
12,547
|
|
| Ratios | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Net Profit Margin |
17.4 %
|
14.6 %
|
24.3 %
|
33.0 %
|
13.3 %
|
13.6 %
|
|
| NCFO / Op.Income |
122.6 %
|
157.3 %
|
156.8 %
|
144.6 %
|
157.1 %
|
141.2 %
|
|
| Current Ratio |
0.8
|
0.8
|
0.9
|
1.1
|
1.0
|
0.9
|
|
| Financial Leverage D/E |
0.66
|
0.65
|
0.59
|
0.42
|
0.44
|
0.36
|
|
| Return on Capital Avg |
10.4 %
|
10.3 %
|
14.0 %
|
12.5 %
|
7.2 %
|
8.1 %
|
|
| Return on Shareholder Equity |
16.7 %
|
13.7 %
|
17.8 %
|
18.9 %
|
9.2 %
|
8.9 %
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available